Director, Search & Evaluation Early TA Lead (CVR and Haem)
Leads strategic sourcing and evaluation of early-stage external innovation in Hematology or Cardiovascular/Renal therapeutic areas. Identifies and advances preclinical to Phase 1 assets, drives due diligence, and shapes partnering strategies within cross-functional teams. Represents the therapeutic area externally, building relationships with biotech, academia, and investors to strengthen the innovation pipeline.